Online Interplay Between Deciding and Acting With Mild Cognitive Impairment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-90
SponsorUniversity of Delaware

About this trial

The investigators aim to understand the interplay and neural structures involved with decision--making and movement for participants with mild cognitive impairment. Rapidly deciding and acting becomes bottlenecked with mild cognitive impairment and Alzheimer's, leading to detrimental outcomes such as falling and car crashes. The investigators work will have a tangible impact by discovering sensitive biomarkers to detect disease onset and pave the way for informed and effective neurorehabilitation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age 45 - 90 years

Perfect or corrected vision

Ability to reach

Neurotypical Age-Matched control participants - No history of neurological disorders or injury.

Disqualifiers

Any injury or condition that impacts reaching

Traumatic brain injury, such as concussion, in the last 6 months.

Neurotypical Age-Matched control participants: Modified Telephone Interview for Cognitive Status (TICS-m) score < 34

Mild Cognitive Impairment participants: Modified Telephone Interview for Cognitive Status (TICS-m) score > 34

Trial design

Design model

Single group

Treatments tested in this trial

  • Reaching Movements

    Behavioral

    participants will perform a perceptual decision making task while moving their hand.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Reaching taskExperimental treatment 1 intervention
Group B: Reaching TaskActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Reaching Movements

Hand position will be recorded throughout each trial during the behavioral task

Time frame
through study completion, an average of 1 year
2

Change in brain mechanical properties

Investigators are assessing change in brain structure through mechanical properties

Time frame
through study completion, an average of 1 year

Secondary outcomes

1

Decision Time

Decision time will be calculated on each trial during the behavioral task

Time frame
through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Delaware

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Institute of General Medical Sciences (NIGMS)

Collaborator